Reuters logo
BRIEF-AbbVie sees slow or flat growth for testosterone products like its AndroGel
April 25, 2014 / 2:07 PM / 3 years ago

BRIEF-AbbVie sees slow or flat growth for testosterone products like its AndroGel

April 25 (Reuters) - AbbVie Inc : * Says expects demand for products like its androgel testosterone drug to be

“slow growing or flat” in future

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below